ALK Chromosome 2
ALK receptor tyrosine kinase
Upload your DNA to see your personal genotypes for variants in ALK.
What This Gene Does
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
Gene Info
Gene Group
"Receptor tyrosine kinases|CD molecules"
Locus Type
gene with protein product
Location
2p23.2-p23.1
Ensembl
ENSG00000171094
Associated Conditions (14)
Neuroblastoma
susceptibility to
3
Hereditary cancer-predisposing syndrome
Ovarian cancer
ALK-related disorder
Ovarian serous cystadenocarcinoma
Familial isolated pituitary adenoma
Diffuse midline glioma
H3 K27-altered
Malignant tumor of urinary bladder
Lung cancer
Rhabdomyosarcoma
Neoplasm
Key Variants
RS1010580453
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1019065457
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1046338903
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1060500214
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1060500225
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1060500231
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS113303272
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS113994090
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS113994091
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1165737526
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1165866210
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
RS1172956542
Conflicting classifications of pathogenicity
Neuroblastoma, susceptibility to, 3
Health Risk
All Variants (365)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1010580453 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1019065457 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1046338903 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1060500214 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1060500225 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1060500231 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS113303272 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS113994090 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS113994091 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1165737526 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1165866210 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1172956542 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1189878579 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1208409389 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1226555490 | Health Risk | Conflicting classifications of pathogenicity | Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to |
| RS1236590521 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1237752481 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1244823020 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1264537420 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1265006535 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1267142388 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1268649558 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1272214012 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1275855734 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1278070199 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1280277994 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1286011012 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1296992304 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1302907379 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1316424431 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1326321652 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1333697872 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1337002578 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1338200771 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1345881154 | Health Risk | Conflicting classifications of pathogenicity | Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to |
| RS1365620880 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1371180882 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1374146241 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS138178848 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS138589984 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS138686378 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1388736375 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1400037080 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS140733978 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS140928266 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS141010693 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS141093002 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS141242925 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS142120301 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |
| RS1430369916 | Health Risk | Conflicting classifications of pathogenicity | Neuroblastoma, susceptibility to, 3 |